Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Exchange Rate Effect (2022 - 2025)

Centessa Pharmaceuticals (CNTA) has disclosed Exchange Rate Effect for 4 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect fell 44.49% to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$448000.0 through Dec 2025, down 136.51% year-over-year, with the annual reading at -$448000.0 for FY2025, 136.51% down from the prior year.
  • Exchange Rate Effect for Q4 2025 was $1.7 million at Centessa Pharmaceuticals, up from -$501000.0 in the prior quarter.
  • The five-year high for Exchange Rate Effect was $3.0 million in Q4 2024, with the low at -$1.9 million in Q3 2024.
  • Average Exchange Rate Effect over 4 years is $61000.0, with a median of -$116500.0 recorded in 2024.
  • Peak annual rise in Exchange Rate Effect hit 701.59% in 2024, while the deepest fall reached 965.45% in 2024.
  • Over 4 years, Exchange Rate Effect stood at $722000.0 in 2022, then tumbled by 169.81% to -$504000.0 in 2023, then surged by 701.59% to $3.0 million in 2024, then crashed by 44.49% to $1.7 million in 2025.
  • According to Business Quant data, Exchange Rate Effect over the past three periods came in at $1.7 million, -$501000.0, and -$113000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.